⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of FenoMark Diagnostics AB and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
FenoMark Diagnostics AB
↗Solna, Sweden
FenoMark Diagnostics is a Swedish biotechnology company focused on biomarker discovery and the development of clinical diagnostic assays. The company leverages mass spectrometry-based proteomics to provide standardized workflows that enable medical professionals to generate actionable clinical insights, particularly for therapy selection in lung cancer.
Spun out from the Karolinska Institutet and SciLifeLab, FenoMark aims to bridge the gap between research-grade proteomics and routine clinical diagnostics. Their mission is to make diagnostics more accurate, informed, and accessible by delivering reliable, high-quality molecular testing solutions.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Almi Invest, Karolinska Institutet Holding, Blue Cabinet
PIPELINE
Stage:Discovery
Lead Drug Stage:Diagnostic assay development
Modalities:Proteomics, Mass Spectrometry
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Karolinska Institutet (Research collaboration), SciLifeLab (Research collaboration)
COMPETITION
Position:Emerging
Competitors:EntroGen
LEADERSHIP
Key Executives:
Santeri Kiviluoto - Co-Founder & CEO
Janne Lehtiö - Co-Founder & Chairman
Lukas Orre - Co-Founder & CSO
Scientific Founders:Janne Lehtiö, Lukas Orre, Santeri Kiviluoto
LINKS
Website:fenomark.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with FenoMark Diagnostics AB. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.